Evidence map›Paper›PMID 39234013›Full record

ArticleRadiology case reports2024

Tubulocystic renal cell carcinoma: A case report of rare tumor.

Abdullah M Al-Jubouri, Ibrahim A Khalil, Abdelkareem Alhyari, Majd Alkabbani, Alaeddin Badawi, Rajen Goyal, Khalid Al Jalham

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdullah M Al-JubouriCollege of Medicine, QU Health, Qatar University, Doha, Qatar.
Ibrahim A KhalilDepartment of Urology, Uro-oncology section, Hamad Medical Corporation, Doha, Qatar.
Abdelkareem AlhyariDepartment of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Majd AlkabbaniDepartment of Urology, Hamad medical corporation, Doha, Qatar.
Alaeddin BadawiDepartment of Urology, Uro-oncology section, Hamad Medical Corporation, Doha, Qatar.
Rajen GoyalDepartment of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Khalid Al JalhamDepartment of Urology, Uro-oncology section, Hamad Medical Corporation, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tubulocystic renal cell carcinoma (RCC) is a rare renal cancer first recognized by the WHO in 2016 as independent disease category, characterized by its typically indolent features and low rates of metastasis. We present a 35-year-old male with tubulocystic RCC diagnosed incidentally on evaluation of flank pain. Magnetic resonance imaging showed Bosniak class 4 renal cyst, although initial computed topography showed a hypodense nonenhancing lesion classified as Bosniak 1 cyst. Patient underwent robotic assisted partial nephrectomy, histopathology confirmed as tubulocystic RCC. This case highlights the importance of considering tubulocystic RCC in the differential diagnoses of renal cysts and other solid renal masses to ensure timely and effective treatment plan.

Indexed as

NephrectomyRenal cell carcinomaRoboticTubulocystic

Identifiers

PMID39234013
PMCPMC11372579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.